Eastman Chemical Company · Healthcare · Chemicals
As of 2026-06-26, Eastman Chemical Company (EMN) has a 3-month relative strength percentile of 36 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.8%, relative volume 2.04×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
36 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
EMN is in a stage 1 base, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -3.4% / 3.1%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
EMN is held by 9 ETFs as of Mar 2026. Top owner: IJR at 0.57% weight, $523M notional. Top 3 carry $1000M.
Top 9 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.57% | $523M |
| VTIVanguard Total Stock Market ETF | 0.01% | $276M |
| VBVanguard Small Cap ETF | 0.12% | $201M |
| VBRVanguard Small Cap Value ETF | 0.21% | $128M |
| VXFVanguard Extended Market ETF | 0.12% | $97M |
| IWRiShares Russell Midcap ETF | 0.07% | $33M |
| IWDiShares Russell 1000 Value ETF | 0.03% | $20M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.01% | $11M |
| IWBiShares Russell 1000 ETF | 0.01% | $6M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EMN Jan avg: 4.75% median: 8.43% win: 75% σ: 7.83% n: 4 2022-04-12 → 2026-05-29 | EMN Feb avg: 2.19% median: 1.60% win: 50% σ: 5.78% n: 4 2022-04-12 → 2026-05-29 | EMN Mar avg: 1.08% median: 0.03% win: 50% σ: 9.98% n: 4 2022-04-12 → 2026-05-29 | EMN Apr avg: -5.44% median: -4.50% win: 0% σ: 4.54% n: 5 2022-04-12 → 2026-05-29 | EMN May avg: 2.33% median: 3.80% win: 80% σ: 6.51% n: 5 2022-04-12 → 2026-05-29 | EMN Jun avg: -4.49% median: -4.03% win: 25% σ: 11.10% n: 4 2022-04-12 → 2026-05-29 (current) | EMN Jul avg: 2.95% median: 3.85% win: 75% σ: 4.27% n: 4 2022-04-12 → 2026-05-29 | EMN Aug avg: -2.46% median: -2.03% win: 0% σ: 2.10% n: 4 2022-04-12 → 2026-05-29 | EMN Sep avg: -8.17% median: -10.06% win: 25% σ: 12.96% n: 4 2022-04-12 → 2026-05-29 | EMN Oct avg: -1.55% median: -4.10% win: 25% σ: 6.63% n: 4 2022-04-12 → 2026-05-29 | EMN Nov avg: 7.22% median: 8.24% win: 75% σ: 6.36% n: 4 2022-04-12 → 2026-05-29 | EMN Dec avg: -2.20% median: -1.58% win: 50% σ: 8.93% n: 4 2022-04-12 → 2026-05-29 |